• Users Online: 97
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2018  |  Volume : 4  |  Issue : 1  |  Page : 3-6

Bilastine: A novel antihistamine


1 Consultant Dermatologist, Sakhiya Skin Clinic, Surat, Gujarat, India
2 Professor of Dermatology, D Y Patil Hospital, Navi Mumbai, Maharashtra, India
3 Shree Skin Centre, Navi Mumbai, Maharashtra, India

Correspondence Address:
Dr. Kiran Godse
D Y Patil Hospital, Navi Mumbai - 400 706, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdd.ijdd_12_18

Rights and Permissions

Bilastine is a new second generation H1-antihistamine approved for the symptomatic treatment of allergic rhinitis (AR) and chronic urticaria (CU) in patients older than 12 years of age. AR and urticaria are very common clinical conditions that represent one of the most frequent reasons for a patient to visit their general practitioner or allergist or dermatologist. Bilastine, with its efficacy and safety profile epitomizes the evolution of research on antihistamines.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed412    
    Printed12    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal